Literature DB >> 7474546

Two different endothelin B receptor subtypes mediate contraction of the rabbit saphenous vein.

M Nishiyama1, K Moroi, L H Shan, M Yamamoto, C Takasaki, T Masaki, S Kimura.   

Abstract

To study endothelin receptor subtypes that mediate venous smooth muscle contraction, effects of some endothelin receptor agonists and antagonists on the rabbit lateral saphenous vein were examined and compared with those on the saphenous artery. In the artery, endothelin (ET)-1 elicited concentration-dependent contractions, while selective ETB-receptor agonists, IRL1620 (Suc-[Glu9,Ala11,15]ET-1(8-21)) and sarafotoxin 6c (S6c) had almost no effect. The ET-1-induced responses shifted in parallel to the right by BQ-123 (cyclo (-D-Trp-D-Asp-Pro-D-Val-Leu-)), an ETA-receptor antagonist, or PD142893 (Ac-D-Dip-Leu-Asp-Ile-Ile-Trp), an ETA/ETB-receptor antagonist, indicating the involvement of the ETA receptor in this response. In the saphenous vein, not only ET-1 and ET-3, but also ETB-receptor agonists, IRL1620, S6c and [Glu9]sarafotoxin 6b ([Glu9]S6b), produced concentration-dependent, BQ-123-insensitive contractions. PD142893 did not affect the ET-1-induced contraction, but it shifted greatly the IRL1620-induced concentration-response curve in parallel to the right. The major components of ET-3-, S6c- and [Glu9]S6b-induced contractions were resistant to PD142893. These results indicate that two different vasoconstrictive ETB-receptor subtypes, ETB1 (sensitive to IRL1620 and PD142893) and ETB2 (insensitive to IRL1620 and PD142893), are located on the smooth muscle of the saphenous vein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474546     DOI: 10.1254/jjp.68.235

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  5 in total

Review 1.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Immortalized schwann cells express endothelin receptors coupled to adenylyl cyclase and phospholipase C.

Authors:  P L Wilkins; D Suchovsky; L N Berti-Mattera
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

3.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

4.  Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.

Authors:  Akira Sato; Keiichi Ebina
Journal:  Inflamm Res       Date:  2013-01-31       Impact factor: 4.575

5.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.